{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:42:02Z","timestamp":1792777322264,"version":"4.5.0"},"reference-count":18,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,10,20]]},"DOI":"10.2967\/jnumed.126.274089","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:35:21Z","timestamp":1792776921000},"page":"jnumed.126.274089","source":"Crossref","is-referenced-by-count":0,"title":["TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of\n                    <sup>212<\/sup>\n                    Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation\u2013Resistant Prostate Cancer"],"prefix":"10.2967","author":[{"given":"Aaron R.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley S.","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind S.","family":"Ravi Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Loo","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Katchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola M.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Crumbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan C.","family":"Baronet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Karmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2026102310351721000_jnumed.126.274089v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026102310351721000_jnumed.126.274089v1.2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.eururo.2024.08.021","article-title":"Association of declining prostate-specific antigen levels with clinical outcomes in patients with metastatic castration-resistant prostate cancer receiving [177Lu]Lu-PSMA-617 in the phase 3 VISION Trial","volume":"86","author":"Armstrong","year":"2024","journal-title":"Eur Urol."},{"key":"2026102310351721000_jnumed.126.274089v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01653-2"},{"key":"2026102310351721000_jnumed.126.274089v1.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186825"},{"key":"2026102310351721000_jnumed.126.274089v1.5","doi-asserted-by":"crossref","unstructured":"Griffiths M Campbell L Latter M . 212Pb PSMA imaging by pair production PET confirms localisation of alpha emissions within tumour lesions. Annual Congress of the European Association of Nuclear Medicine, October 4\u20138, 2025 | Barcelona, Spain, EANM Innovation, Volume 1, Supplement, 2025: [abstract OP-290].","DOI":"10.1016\/S3051-2913(25)00004-7"},{"key":"2026102310351721000_jnumed.126.274089v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1650"},{"key":"2026102310351721000_jnumed.126.274089v1.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267189"},{"key":"2026102310351721000_jnumed.126.274089v1.8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00259-023-06529-1","article-title":"First-in-human SPECT\/CT imaging of [212Pb]Pb-VMT-\u03b1-NET in a patient with metastatic neuroendocrine tumor","volume":"51","author":"Michler","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026102310351721000_jnumed.126.274089v1.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269707"},{"key":"2026102310351721000_jnumed.126.274089v1.10","doi-asserted-by":"crossref","unstructured":"Greystoke A Brown S Chalmers A . Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose. Int J Radiat Oncol Biol Phys. 2026:S0360-3016(26)03921\u20130.","DOI":"10.1016\/j.ijrobp.2026.06.3067"},{"key":"2026102310351721000_jnumed.126.274089v1.11","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Oncology Center of Excellence. Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development Guidance for Industry. August 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/oncology-therapeutic-radiopharmaceuticals-dosage-optimization-during-clinical-development. Updated August 18, 2025. Accessed October 14, 2026."},{"key":"2026102310351721000_jnumed.126.274089v1.12","doi-asserted-by":"crossref","unstructured":"O\u2019Mahoney E Griffiths M Ngai S . Radiation safety with 212Pb-based therapeutics from clinical experience with 212Pb-ADVC001 (TheraPb): dose to staff and members of the public. Annual Congress of the European Association of Nuclear Medicine, October 4\u20138, 2025 | Barcelona, Spain, EANM Innovation, Volume 1, Supplement, 2025: [abstract OP-703].","DOI":"10.1016\/S3051-2913(25)00004-7"},{"key":"2026102310351721000_jnumed.126.274089v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2026102310351721000_jnumed.126.274089v1.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.4487"},{"key":"2026102310351721000_jnumed.126.274089v1.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2026102310351721000_jnumed.126.274089v1.16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233460"},{"key":"2026102310351721000_jnumed.126.274089v1.17","doi-asserted-by":"crossref","first-page":"102862","DOI":"10.1016\/j.eclinm.2024.102862","article-title":"Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial","volume":"77","author":"Herrmann","year":"2024","journal-title":"EClinicalMedicine."},{"key":"2026102310351721000_jnumed.126.274089v1.18","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/56\/3\/012"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.274089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:35:22Z","timestamp":1792776922000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.274089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":18,"alternative-id":["10.2967\/jnumed.126.274089"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.274089","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]}}}